U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C20H23NO.ClH
Molecular Weight 329.864
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of OXAPROTILINE HYDROCHLORIDE

SMILES

Cl.CNCC(O)CC12CCC(C3=CC=CC=C13)C4=CC=CC=C24

InChI

InChIKey=MUOSVLIKDZRWMP-UHFFFAOYSA-N
InChI=1S/C20H23NO.ClH/c1-21-13-14(22)12-20-11-10-15(16-6-2-4-8-18(16)20)17-7-3-5-9-19(17)20;/h2-9,14-15,21-22H,10-13H2,1H3;1H

HIDE SMILES / InChI

Molecular Formula C20H23NO
Molecular Weight 293.4027
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Oxaprotiline (also known as hydroxymaprotiline) is a norepinephrine reuptake inhibitor and blocked the histamine H1 receptor. Oxaprotiline was studied in the treatment of hospitalized depressive patients. However, this drug has never been marketed.

Approval Year

PubMed

PubMed

TitleDatePubMed
Psychosocial determinants of recovery in depression.
2008
Modulation of electrically evoked serotonin release in cultured rat raphe neurons.
2007-03
PET imaging of norepinephrine transporters.
2006
Synthesis and C-11 labeling of three potent norepinephrine transporter selective ligands ((R)-nisoxetine, lortalamine, and oxaprotiline) for comparative PET studies in baboons.
2005-08-01
Comparative evaluation of positron emission tomography radiotracers for imaging the norepinephrine transporter: (S,S) and (R,R) enantiomers of reboxetine analogs ([11C]methylreboxetine, 3-Cl-[11C]methylreboxetine and [18F]fluororeboxetine), (R)-[11C]nisoxetine, [11C]oxaprotiline and [11C]lortalamine.
2005-07
Alpha2-adrenoceptors modulating neuronal serotonin release: a study in alpha2-adrenoceptor subtype-deficient mice.
2001-02
Differential effects of the enantiomers R(-) and S(+) oxaprotiline on major endogenous depression, the sleep EEG and neuroendocrine secretion: studies on depressed patients and normal controls.
1993-06
Oxaprotiline enantiomers given repeatedly and brain alpha-adrenoceptors.
1990
The influence of oxaprotiline enantiomers given repeatedly on the behavioural effects of d-amphetamine and dopamine injected into the nucleus accumbens.
1988-01-12
(+)-Oxaprotiline but not (-)-oxaprotiline given chronically potentiates the aggressive behaviour induced by clonidine.
1983-03
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:17:52 GMT 2025
Edited
by admin
on Mon Mar 31 19:17:52 GMT 2025
Record UNII
9DOW99I129
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
OXAPROTILINE HYDROCHLORIDE
MART.   USAN   WHO-DD  
USAN  
Official Name English
NSC-310406
Preferred Name English
9,10-ETHANOANTHRACENE-9(10H)-ETHANOL, .ALPHA.-((METHYLAMINO)METHYL)-, HYDROCHLORIDE, (±)-
Systematic Name English
OXAPROTILINE HYDROCHLORIDE [MART.]
Common Name English
OXAPROTILINE HYDROCHLORIDE [USAN]
Common Name English
(±)-.ALPHA.-((METHYLAMINO)METHYL)-9,10-ETHANOANTHRACENE-9(10H)-ETHANOL HYDROCHLORIDE
Systematic Name English
C-49802B-BA
Code English
Oxaprotiline hydrochloride [WHO-DD]
Common Name English
Code System Code Type Description
NSC
310406
Created by admin on Mon Mar 31 19:17:52 GMT 2025 , Edited by admin on Mon Mar 31 19:17:52 GMT 2025
PRIMARY
NCI_THESAURUS
C175182
Created by admin on Mon Mar 31 19:17:52 GMT 2025 , Edited by admin on Mon Mar 31 19:17:52 GMT 2025
PRIMARY
SMS_ID
300000055562
Created by admin on Mon Mar 31 19:17:52 GMT 2025 , Edited by admin on Mon Mar 31 19:17:52 GMT 2025
PRIMARY
PUBCHEM
38206
Created by admin on Mon Mar 31 19:17:52 GMT 2025 , Edited by admin on Mon Mar 31 19:17:52 GMT 2025
PRIMARY
ChEMBL
CHEMBL2111067
Created by admin on Mon Mar 31 19:17:52 GMT 2025 , Edited by admin on Mon Mar 31 19:17:52 GMT 2025
PRIMARY
ECHA (EC/EINECS)
254-249-7
Created by admin on Mon Mar 31 19:17:52 GMT 2025 , Edited by admin on Mon Mar 31 19:17:52 GMT 2025
PRIMARY
FDA UNII
9DOW99I129
Created by admin on Mon Mar 31 19:17:52 GMT 2025 , Edited by admin on Mon Mar 31 19:17:52 GMT 2025
PRIMARY
CAS
39022-39-4
Created by admin on Mon Mar 31 19:17:52 GMT 2025 , Edited by admin on Mon Mar 31 19:17:52 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY